1
/
of
0
FDA Summary Basis of Approval for GLYDO Jelly 2% (NDA A201094) – Sagent Pharmaceuticals Inc.
FDA Summary Basis of Approval for GLYDO Jelly 2% (NDA A201094) – Sagent Pharmaceuticals Inc.
Regular price
$69.00 USD
Regular price
Sale price
$69.00 USD
Unit price
/
per
Original Request Contents: Summary Basis of Approval (SBOA) of GLYDO (Lidocaine Hydrochloride) jelly 2% (NDA A201094) held by Sagent Pharmaceuticals Inc.
Couldn't load pickup availability
- Status: Pending Fast-Track Request
- Delivery: Approximately 1 to 2 weeks when the FOIA office is operating at regular capacity
NOTE: This document is not currently in our library. Upon purchase, we will request the document from the FDA FOIA office. Learn more about Fast-Track Requests here.
View full details